Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Apr;95(4):1426. doi: 10.1172/JCI117811

Somatic cell gene therapy for a trait as complex as hypertension?

J A Martinez, D T O'Connor
PMCID: PMC295622  PMID: 7706444

Full text

PDF

Page 1426

1426

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson W. F. Human gene therapy. Science. 1992 May 8;256(5058):808–813. doi: 10.1126/science.1589762. [DOI] [PubMed] [Google Scholar]
  2. Berry T. D., Hasstedt S. J., Hunt S. C., Wu L. L., Smith J. B., Ash K. O., Kuida H., Williams R. R. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension. 1989 Jan;13(1):3–8. doi: 10.1161/01.hyp.13.1.3. [DOI] [PubMed] [Google Scholar]
  3. Geller R. G., Margolius H. S., Pisano J. J., Keiser H. R. Urinary kallikrein excretion in spontaneously hypertensive rats. Circ Res. 1975 Jun;36(6 Suppl 1):103–106. doi: 10.1161/01.res.36.6.103. [DOI] [PubMed] [Google Scholar]
  4. Goguen L. A., April M. M., Karmody C. S., Carter B. L. Self-induced pneumoparotitis. Arch Otolaryngol Head Neck Surg. 1995 Dec;121(12):1426–1429. doi: 10.1001/archotol.1995.01890120082017. [DOI] [PubMed] [Google Scholar]
  5. Kasahara N., Dozy A. M., Kan Y. W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 1994 Nov 25;266(5189):1373–1376. doi: 10.1126/science.7973726. [DOI] [PubMed] [Google Scholar]
  6. Madeddu P., Gherli T., Bacciu P. P., Maioli M., Glorioso N. A kallikrein-like enzyme in human vascular tissue. Am J Hypertens. 1993 May;6(5 Pt 1):344–348. doi: 10.1093/ajh/6.5.344. [DOI] [PubMed] [Google Scholar]
  7. Margolis H. S., Geller R., Pisano J. J., Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet. 1971 Nov 13;2(7733):1063–1065. doi: 10.1016/s0140-6736(71)90382-5. [DOI] [PubMed] [Google Scholar]
  8. Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., von der Leyen H., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994 Apr;93(4):1458–1464. doi: 10.1172/JCI117123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pravenec M., Kren V., Kunes J., Scicli A. G., Carretero O. A., Simonet L., Kurtz T. W. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension. 1991 Feb;17(2):242–246. doi: 10.1161/01.hyp.17.2.242. [DOI] [PubMed] [Google Scholar]
  10. Simon R. H., Engelhardt J. F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J. M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther. 1993 Dec;4(6):771–780. doi: 10.1089/hum.1993.4.6-771. [DOI] [PubMed] [Google Scholar]
  11. Wang C., Chao L., Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest. 1995 Apr;95(4):1710–1716. doi: 10.1172/JCI117847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 1993 Jul 9;261(5118):209–211. doi: 10.1126/science.7687073. [DOI] [PubMed] [Google Scholar]
  13. Zinner S. H., Margolius H. S., Rosner B., Kass E. H. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation. 1978 Nov;58(5):908–915. doi: 10.1161/01.cir.58.5.908. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES